Print this page
Leukemia Inhibitory Factor Levels after Allogeneic Transplantation.
The primary objective is to determine LIF levels in blood at various times during the transplant process.
Protocol Number:
022104
Phase:
N/A
Applicable Disease Sites:
Leukemia, other
Leukemia, not otherwise specified
Leukemia, not otherwise specified
Scope:
Local
Participating Institutions:
- Rutgers Cancer Institute of New Jersey
- Principal Investigator
- Amer Assal MD
- Principal Investigator
For further information about clinical trials, please contact us at 732-235-7356.